Dopa-responsive dystonia
Zuletzt aktualisiert 7 Nov 2023
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Dopa-responsive dystonia is a disorder that involves involuntary muscle contractions, tremors, and other uncontrolled movements (dystonia). The features of this condition range from mild to severe. This form of dystonia is called dopa-responsive dystonia because the signs and symptoms typically improve with sustained use of a medication known as L-Dopa.
Videoauswahl für Genetische ErkrankungenVideothek
Beschreibung
Dopa-responsive dystonia is a disorder that involves involuntary muscle contractions, tremors, and other uncontrolled movements (dystonia). The features of this condition range from mild to severe. This form of dystonia is called dopa-responsive dystonia because the signs and symptoms typically improve with sustained use of a medication known as L-Dopa.
Signs and symptoms of dopa-responsive dystonia usually appear during childhood, most commonly around age 6. The first signs of the condition are typically the development of inward- and upward-turning feet (clubfeet) and dystonia in the lower limbs. The dystonia spreads to the upper limbs over time; beginning in adolescence, the whole body is typically involved. Affected individuals may have unusual limb positioning and a lack of coordination when walking or running. Some people with this condition have sleep problems or episodes of depression more frequently than would normally be expected.
Over time, affected individuals often develop a group of movement abnormalities called parkinsonism. These abnormalities include unusually slow movement (bradykinesia), muscle rigidity, tremors, and an inability to hold the body upright and balanced (postural instability).
The movement difficulties associated with dopa-responsive dystonia usually worsen with age but stabilize around age 30. A characteristic feature of dopa-responsive dystonia is worsening of movement problems later in the day and an improvement of symptoms in the morning, after sleep (diurnal fluctuation).
Rarely, the movement problems associated with dopa-responsive dystonia do not appear until adulthood. In these adult-onset cases, parkinsonism usually develops before dystonia, and movement problems are slow to worsen and do not show diurnal fluctuations.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
DRD
Dystonia 5, dopa-responsive type
Hereditary progressive dystonia with marked diurnal fluctuation
Related patient information and medicines

Patient information leaflet
Dystonie
A dystonia is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. Some neurological conditions can cause dystonia such as: Parkinson's disease Parkinson's disease. Medications More generalised or childhood forms may be treated with medication such as levodopa, diazepam or baclofen: Levodopa ( co-beneldopa Co-beneldopa.

Patient information leaflet
Huntington-Krankheit
Symptoms can develop at any time, but they tend to emerge between the age of 30 and 50. Movement problems Huntington's disease can cause both involuntary and impaired movement problems, which include: Jerky, involuntary movements in the head, face, arms or legs (chorea). Muscle spasms mostly in the shoulders, neck, arms and legs ( dystonia.

Patient information leaflet
Parkinson-Krankheit
Der Mangel von dopamine leads to a movement disorder with Parkinson's disease symptoms. Parkinson-Krankheit Symptome Der brain cells and nerves affected in Parkinson's disease (PD) normally help to produce smooth, co-ordinated movements von muscles. When this system goes wrong, movement disorders (motor symptoms) occur. Stiffness of muscles.

Patient information leaflet
Blepharospasmus
In the UK, if you have blepharospasm you must notify the Driver and Vehicle Licensing Agency (DVLA). What is blepharospasm. Most people blink 10 to 20 times per minute, a little less when concentrati... An increase in blink frequency and strength is called blepharospasm. Blepharospasmus is a type von focal dystonia. 'Dystonia' means abnormal,.

Patient information leaflet
Schiefhals
Torticollis means 'twisted neck'. It is also often called 'wry neck'. Fixed torticollis can also arise due to incorrect development or fusion of the vertebra (neck bones) in babies. Cervical dystonia Cervical dystonia (also known as spasmodic torticollis) is a problem where abnormal movements develop in the muscles of the neck. It occurs most.

Patient information leaflet
Antipsychotische Medikamente
Antipsychotika sind Medikamenten that are mainly used to treat schizophrenia or mania caused by bipolare Störung. Akathisia - this is like a restlessness of the legs. Dystonia Dystonia - this means abnormal movements of the face and body. Tardive dyskinesia (TD) - this is a movement disorder that can occur in some people who have taken antipsychotics.
Weiterführende Lektüre und Referenzen
- Dopa-responsive dystonia; MedlinePlus, National Library of Medicine.
- Arrabal L, Teresa L, Sanchez-Alcudia R, Castro M, Medrano C, Gutierrez-Solana L, Roldan S, Ormazabal A, Perez-Cerda C, Merinero B, Perez B, Artuch R, Ugarte M, Desviat LR. Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant. Neurogenetics. 2011 Aug;12(3):183-91. doi: 10.1007/s10048-011-0279-4. Epub 2011 Mar 24.
- Asmus F, Gasser T. Dystonia-plus syndromes. Eur J Neurol. 2010 Jul;17 Suppl 1:37-45. doi: 10.1111/j.1468-1331.2010.03049.x.
- Bonafe L, Thony B, Penzien JM, Czarnecki B, Blau N. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet. 2001 Aug;69(2):269-77. doi: 10.1086/321970. Epub 2001 Jul 6.
- Schiller A, Wevers RA, Steenbergen GC, Blau N, Jung HH. Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology. 2004 Oct 26;63(8):1524-6. doi: 10.1212/01.wnl.0000142083.47927.0a.
- Segawa M. Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med J. 2009 Jan-Feb;32(1):1-11.
- Stafford BM, Klein E, Haskins K, Liebman E, Teslow T. Depth studies: illustrated anatomies from Vesalius to Vicq d'Azyr. Caduceus. 1992 Autumn;8(2):39-48. No abstract available.
- Steinberger D, Blau N, Goriuonov D, Bitsch J, Zuker M, Hummel S, Muller U. Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics. 2004 Sep;5(3):187-90. doi: 10.1007/s10048-004-0182-3. Epub 2004 Jul 6.
- Trender-Gerhard I, Sweeney MG, Schwingenschuh P, Mir P, Edwards MJ, Gerhard A, Polke JM, Hanna MG, Davis MB, Wood NW, Bhatia KP. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):839-45. doi: 10.1136/jnnp.2008.155861. Epub 2009 Mar 29.
- Wu ZY, Lin Y, Chen WJ, Zhao GX, Xie H, Murong SX, Wang N. Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families. Clin Genet. 2008 Dec;74(6):513-21. doi: 10.1111/j.1399-0004.2008.01039.x. Epub 2008 Jun 11.
- Yeung WL, Wong VC, Chan KY, Hui J, Fung CW, Yau E, Ko CH, Lam CW, Mak CM, Siu S, Low L. Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency. J Child Neurol. 2011 Feb;26(2):179-87. doi: 10.1177/0883073810377014. Epub 2010 Sep 7.
- Zirn B, Steinberger D, Troidl C, Brockmann K, von der Hagen M, Feiner C, Henke L, Muller U. Frequency of GCH1 deletions in Dopa-responsive dystonia. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):183-6. doi: 10.1136/jnnp.2007.128413. Epub 2007 Sep 26.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
7 Nov 2023 | Neueste Version
1 May 2012 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

